SUZANNE COOPER: Open Payments
NPI 1912776915 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 95 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $2,856 · 2025 $1,831
Food & beverage: $1,831
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $378 |
| Lilly USA, LLC | 14 | $215 |
| ABBVIE INC. | 15 | $174 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| Exact Sciences Corporation | 4 | $82 |
| PFIZER INC. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
Products named: Wegovy, MOUNJARO, Ozempic, VRAYLAR, DUPIXENT, NURTEC ODT, Kerendia, PANZYGA.
Industry payments across FL — which companies pay providers there.
